Source:http://linkedlifedata.com/resource/pubmed/id/12674827
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2003-4-4
|
pubmed:abstractText |
Rifampicin and isoniazid are the most important first line drugs used in the treatment of tuberculosis. These drugs are also used in combination with other medications to treat co-infections. It, therefore, becomes important to study the effect of these drugs on the drug metabolizing system, namely, cytochrome P-450, not only in the host but also in the bacteria. We report the effect of rifampicin and isoniazid on the cytochrome P-450 activity in Mycobacterium smegmatis and M. tuberculosis H37Rv.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0971-5916
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
140-4
|
pubmed:meshHeading | |
pubmed:year |
2002
|
pubmed:articleTitle |
Effect of rifampicin & isoniazid on cytochrome P-450 in mycobacteria.
|
pubmed:affiliation |
Tuberculosis Research Centre (ICMR), Chennai, India.
|
pubmed:publicationType |
Journal Article
|